Abstract
Durvalumab (Imfinzi (R)), a therapeutic human monoclonal antibody which binds to and blocks the activity of the immunosuppressive programmed death-lig......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
